x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:03:48

Elixir Energy advances gas projects in Queensland and...

Proactive - Interviews for investors ·

2024/03/19

Elixir Energy Ltd (ASX:EXR) managing director Neil Young sits down with Proactive’s Jonathan Jackson to discuss the significant strides the company is making in de-risking its gas projects in Queensland and Mongolia. Its Daydream-2 well at the Grandis Project in Queensland is set to undergo rigorous stimulation and flow testing activities, managed by Halliburton, through mid-year. This activity in the Taroom Trough is generating increasing interest in the gas sector. In parallel, Elixir continues to

en

00:07:00

Celsius Resources secures key mining permit for MCB...

Proactive - Interviews for investors ·

2024/03/19

Celsius Resources Ltd (ASX:CLA, AIM:CLA) managing director Peter Hume tells Proactive's Stephen Gunnion the company has achieved a significant milestone by being granted a mining permit for the MCB project, marking a pivotal transition from exploration to mineral resource development. This permit, valid for 25 years and renewable for a further 25, encompasses extensive exploration and development rights within the project area. The MCB project is located in the Philippines and is known for its

en

00:03:15

Galileo Mining identifies drill targets ahead of...

Proactive - Interviews for investors ·

2024/03/19

As it moves a step closer to a new drilling season, Galileo Mining Ltd (ASX:GAL) managing director Brad Underwood sits down with Jonathan Jackson to discuss the program and identified targets. The targets, identified through modelling of induced polarisation (IP) survey data, revealed strong chargeable anomalies near the notable Callisto nickel-palladium deposit. With drilling planned to start in late April, Galileo will test these anomalies for economic mineralisation, focusing on disseminated

en

00:03:44

Alkane Resources nears Kaiser resource upgrade with...

Proactive - Interviews for investors ·

2024/03/19

On the brink of significantly upgrading the mineral resource estimate for its Kaiser deposit in the Northern Molong Porphyry Project in New South Wales, Alkane Resources Ltd (ASX:ALK) managing director Nic Earner takes Proactive’s Jonathan Jackson through the latest drilling results. Alkane has delivered the highest gold grades observed to date at the site. Earner highlights the remarkable findings from the final 12,000-metre round of drilling, which confirmed the presence of high-grade sections

en

00:07:52

OzAurum to start drilling at Boca Rica Lithium Project

Proactive - Interviews for investors ·

2024/03/19

OzAurum Resources Ltd (ASX:OZM) CEO and managing director Andrew Pumphrey sits down with Proactive’s Jonathan Jackson to discuss an upcoming drilling program at Boca Rica Lithium Project in Brazil, following the identification of a spodumene zone. The company plans to start drilling in the next three to four weeks, contingent on weather and the receipt of environmental permits. Pumphrey emphasised the project's potential for a major lithium discovery, highlighting the strategic scale of the site and

en

00:07:06

Ionic Rare Earths on track to be first ASX producer...

Proactive - Interviews for investors ·

2024/03/18

Ionic Rare Earths Ltd (ASX:IXR) managing director Tim Harrison joins Jonathan Jackson in the Proactive studio as the company sets itself to become the first ASX-listed company to produce magnet rare earth oxides (REOs) from recycled wind turbines. Harrison highlights the company's journey towards becoming a major producer of recycled separated magnet REO, a milestone that positions IonicRE as a frontrunner in establishing a sustainable supply chain outside China. IonicRE's innovative approach

en

00:05:25

Xeris Biopharma Surpasses 2023 Expectations with...

Proactive - Interviews for investors ·

2024/03/18

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections and achieving cash positivity in Q4. Xeris Biopharma, described as a multifaceted entity with three commercial assets growing in 2023, also benefits from proprietary technologies and has partnerships with

en

00:04:49

Lexaria Bioscience Revolutionizes Drug Delivery with...

Proactive - Interviews for investors ·

2024/03/18

Lexaria BioScience CEO Chris Bunka joined Steve Darling from Proactive to share significant updates regarding its focus on DehydraTECH, a patented drug delivery formulation and processing platform technology aimed at improving the oral delivery of active pharmaceutical ingredients. Lexaria BioScience has initiated its second DehydraTECH-powered glucagon-like peptide 1 (GLP-1) human pilot study. This randomized, crossover, placebo-controlled investigation will compare three dose formulations, each

en

00:11:52

HANetf founder and co-CEO discusses shift to active...

Proactive - Interviews for investors ·

2024/03/18

HANetf founder and co-CEO Hector McNeil tells Proactive's Stephen Gunnion about shifting trends in the exchange-traded fund (ETF) market in the United States, indicating a big move towards active management within ETFs. Despite the European market lagging behind the US by three to five years, with a significant gap in market size—$2 trillion in Europe versus $8 trillion in the US—there is a notable increase in the proportion of active ETFs. In the US, approximately 75% of new ETFs are active,

en

00:03:40

Awale Resources reports more significant assay...

Proactive - Interviews for investors ·

2024/03/18

Awale Resources Ltd (TSX-V:ARIC) CEO Andrew Chubb shares positive assay results from follow-up drilling at the new gold-copper discovery at the BBM Target within the Odienné Project in Côte d'Ivoire with Proactive's Stephen Gunnion. Initially discovered in January with four initial drill holes spaced 500 metres apart, subsequent drilling improved results, tracking down a plunge with broader intercepts. The most notable result was 75 metres at 2.4 grams per tonne equivalent, among other similarly

en

00:10:03

Immunic CMO discusses complexities of multiple...

Proactive - Interviews for investors ·

2024/03/18

Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month, highlighting the disease's impact, development, and the unmet medical needs of patients. MS, a lifelong autoimmune disease more prevalent in women than men, begins typically in early adulthood. It manifests in various forms, starting with relapsing-remitting MS, characterized by relapses and MRI

en

00:04:26

Valeo Pharma Q1 numbers shows asthma product revenues...

Proactive - Interviews for investors ·

2024/03/18

Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the first quarter ended January 31, 2024. Valeo Pharma reported revenues of $13.5 million in Q1-24, compared to $13.1 million in Q1-23 and $13.1 million in Q4-23, representing a 3% increase. The company recorded an adjusted gross profit of $3.9 million in Q1-24, similar to the figure in Q1-23, and a significant increase from $2.1 million in Q4-23, marking an 81% rise. Saviuk told

en

00:05:57

Calinex Mines releases preliminary data from...

Proactive - Interviews for investors ·

2024/03/18

Calinex Mines CEO Max Porterfield joined Steve Darling from Proactive to share preliminary results from the geophysical survey conducted at the Pine Bay Project in the Flin Flon Mining District of Manitoba. The survey aims to enhance Callinex's extensive geophysical data set, supporting exploration efforts focused on expanding high-grade copper, gold, silver, and zinc-rich Volcanogenic Massive Sulphide (VMS) deposits at the Project. The project includes several high-grade copper deposits, with the

en

00:08:02

Frontier IP returns to profit with strategic...

Proactive - Interviews for investors ·

2024/03/18

Frontier IP Group PLC (AIM:FIPP) CEO Neil Crabb discusses the company's interim results in an interview with Proactive's Stephen Gunnion, highlighting a return to profitability and a good performance despite challenging market conditions. The firm reported a profit of £1.4 million in the first half, attributed to the rising value of its portfolio, primarily driven by external fundings. Additionally, the company successfully exited its investment in CNT, realising a substantial return of

en

00:04:11

NextEnergy Solar Fund unveils significant solar farm...

Proactive - Interviews for investors ·

2024/03/18

NextEnergy Capital Investment Director and UK Legal Counsel Stephen Rosser joins Proactive's Stephen Gunnion with details of NextEnergy Solar Fund's first two international solar co-investments in collaboration with NextPower III ESG (NPIII ESG). Rosser oversees the daily operations of the NextEnergy Solar Fund Ltd (LSE:NESF), a part of the FTSE 250 index, working closely with the CEO, CIO, and the investment committee. NextEnergy Capital recently announced the energisation of two solar farms in

en

00:03:39

Faron Pharmaceuticals reports promising phase 1...

Proactive - Interviews for investors ·

2024/03/18

Faron Pharmaceuticals Limited (AIM:FARN) chief executive Dr Markku Jalkanen joins Proactive's Stephen Gunnion with additional positive data from the Phase 1 study of the ongoing bexmarilimab (BEXMAB) trial that has moved into Phase 2 for higher-risk (HR) myelodysplastic syndrome (MDS) patients failed on previous hypomethylating agent (HMA). Dr Jalkanen said the study demonstrated promising results in reducing cancer cells and extending life expectancy in patients. He highlighted the durability and

en

00:05:52

Celsius Resources secures key mining permit for MCB...

Proactive - Interviews for investors ·

2024/03/18

Celsius Resources Ltd (ASX:CLA, AIM:CLA) managing director Peter Hume tells Proactive's Stephen Gunnion the company has achieved a significant milestone by being granted a mining permit for the MCB project, marking a pivotal transition from exploration to mineral resource development. This permit, valid for 25 years and renewable for a further 25, encompasses extensive exploration and development rights within the project area. The MCB project is located in the Philippines and is known for its

en

00:01:07

FTSE edges higher in early trade, Pfizer sells down...

Proactive - Interviews for investors ·

2024/03/18

The FTSE 100 edged higher as the markets opened, with investors bracing for a busy week of macro news. On Wednesday, inflation data will be released, before the Bank of England meets on Thursday to decide whether to maintain interest rates at 5.25% or drop them for the first time since August 2023. In company news, Aviva announced the sale of its Singapore Life stake for £937 million as it continues to streamline its focus towards Irish, British and Canadian markets. Additionally, Pfizer has

en

00:06:09

Versarien advances in global graphene market with...

Proactive - Interviews for investors ·

2024/03/15

Versarien PLC (AIM:VRS, OTC:VRSRF) CEO Stephen Hodge speaks to Proactive's Stephen Gunnion about the significant steps the company has taken to refine its business strategy and focus on its core technologies and intellectual properties (IP). In a notable move, the company has sold its Korean assets, including equipment and IP related to graphene manufacturing by chemical vapour deposition (CVD), to MCK Tech, a South Korean graphene company. This sale, valued at approximately £604,000, includes the

en

00:05:05

Abingdon Health CEO discusses strong interim results,...

Proactive - Interviews for investors ·

2024/03/15

Abingdon Health PLC (AIM:ABDX) CEO and co-founder Chris Yates discusses the company's interim results and business operations in an interview with Proactive's Stephen Gunnion. Abingdon Health is a lateral flow, contract development, and manufacturing organisation (CDMO), supporting customers from product ideation to commercial success. It offers services including development, scale-up manufacturing, regulatory and analytical laboratory provision, and packaging. Yates said a 117% revenue

en

4,685 results

Similar Podcasts

Bloomberg Talks

Bloomberg

Minute Briefing

The Wall Street Journal

Fintech Insider Podcast by 11:FS

11:FS

Midday News

Multimedia Ghana

Best of Business

Newstalk ZB